{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:40:04Z","timestamp":1793648404732,"version":"4.5.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ygyno.2017.12.021","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T18:41:04Z","timestamp":1513881664000},"page":"349-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Clinical characteristics associated with racial disparities in endometrial cancer outcomes: A surveillance, epidemiology and end results analysis"],"prefix":"10.1016","volume":"148","author":[{"given":"Shivani","family":"Sud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Eblan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2017.12.021_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016: cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0010","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975\u20132013, National Cancer Institute. Bethesda, MD, http:\/\/seer.cancer.gov\/csr\/1975_2013\/, (based on November 2015 SEER data submission, posted to the SEER web site, April 2016). n.d."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/107327480901600108","article-title":"Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer","volume":"16","author":"Allard","year":"2009","journal-title":"Cancer Control. J. Moffitt Cancer Cent."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0020","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/1055-9965.EPI-15-0316","article-title":"The growing burden of endometrial cancer: a major racial disparity affecting Black women","volume":"24","author":"Cote","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0025","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/cncr.24160","article-title":"Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time","volume":"115","author":"Wright","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2017.12.021_bb0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-0528.2011.03201.x","article-title":"Cancer of the body of the uterus: trends in mortality and incidence in England, 1985\u20132008: uterine cancer incidence and mortality","volume":"119","author":"Duncan","year":"2012","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0035","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.canep.2013.03.008","article-title":"Recent changes in endometrial cancer trends among menopausal-age US women","volume":"37","author":"Wartko","year":"2013","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0040","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00125-007-0681-5","article-title":"Diabetes mellitus and risk of endometrial cancer: a meta-analysis","volume":"50","author":"Friberg","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.ygyno.2017.12.021_bb0045","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.2105\/AJPH.94.12.2104","article-title":"Endometrial cancer: socioeconomic status and racial\/ethnic differences in stage at diagnosis, treatment, and survival","volume":"94","author":"Madison","year":"2004","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ygyno.2017.12.021_bb0050","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1200\/JCO.2003.01.218","article-title":"Differences in treatment and outcome between African-American and White women with endometrial cancer","volume":"21","author":"Randall","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0055","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2629::AID-CNCR30>3.0.CO;2-2","article-title":"The National Cancer Data Base report on endometrial carcinoma in African-American women","volume":"83","author":"Hicks","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2017.12.021_bb0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/cncr.22797","article-title":"Racial disparities in blacks with gynecologic cancers","volume":"110","author":"Farley","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2017.12.021_bb0065","unstructured":"NCCN Clinical practice guidelines in oncology (NCCN GuidelinesTM) uterine neoplasms version 1. 2017. NCCN.org, http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp. n.d."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0070","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/AOG.0000000000000605","article-title":"Racial disparities in treatment of high-grade endometrial cancer in the Medicare population","volume":"125","author":"Rauh-Hain","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0075","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1158\/1055-9965.EPI-11-0735","article-title":"The impact of race and comorbidity on survival in endometrial cancer","volume":"21","author":"Olson","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0080","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0085","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0090","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"ASTEC\/EN.5 Study Group","year":"2009","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0100","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0105","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial","volume":"27","author":"Nout","year":"2009","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0110","series-title":"Cochrane Database Syst. Rev","article-title":"Adjuvant chemotherapy for advanced endometrial cancer","author":"Galaal","year":"2014"},{"key":"10.1016\/j.ygyno.2017.12.021_bb0115","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ijrobp.2015.06.013","article-title":"Brachytherapy is associated with improved survival in inoperable stage I endometrial adenocarcinoma: a population-based analysis","volume":"93","author":"Acharya","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0120","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/COC.0b013e3181b0c266","article-title":"Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?","volume":"33","author":"Crosby","year":"2010","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0125","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijrobp.2013.11.003","article-title":"Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma","volume":"88","author":"Elshaikh","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/COC.0000000000000065","article-title":"Adjuvant pelvic radiation therapy\u00b1vaginal brachytherapy in patients with high-risk stage I or stage II uterine papillary serous, clear cell, and high-grade endometrioid carcinoma","volume":"39","author":"Nagar","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0135","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijrobp.2007.05.048","article-title":"Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis","volume":"70","author":"Rossi","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0140","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ygyno.2013.05.020","article-title":"Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States","volume":"130","author":"Long","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0145","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/cncr.24769","article-title":"Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a gynecologic oncology group study","volume":"116","author":"Farley","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2017.12.021_bb0150","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer: molecular classification of EC","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2017.12.021_bb0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2011.03.010","article-title":"Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database","volume":"122","author":"Fedewa","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.12.021_bb0160","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ygyno.2017.01.024","article-title":"Disparities in receipt of care for high-grade endometrial cancer: a National Cancer Data Base analysis","volume":"145","author":"Bregar","year":"2017","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817316074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817316074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T00:25:33Z","timestamp":1535156733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817316074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0090825817316074"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.12.021","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics associated with racial disparities in endometrial cancer outcomes: A surveillance, epidemiology and end results analysis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}